Zimmer Biomet Holdings Inc. (ZBH) exhibits 69.7% gross margins and 4.6% return on invested capital within Health Care (Industrial Specialties), balanced against a 19.3x enterprise multiple and 4.8% implied options volatility.
Sustained 69.7% gross profitability converts into 13.3% operating margin and 4.6% ROIC, outpacing sector cost of capital.
ROIC: 4.6% // GM: 69.7%YoY revenue trajectory of +7.2% paired with 7.92% free cash flow yield supports self-funded R&D and capital return.
REV YOY: +7.2% // FCF YLD: 7.92%Altman Z-Score of 2.42 and Piotroski F-Score of 8/9 indicate low near-term refinancing stress.
ALTMAN Z: 2.42 // F-SCORE: 8/9Trading at 26.4x trailing P/E (24.6x Fwd P/E) leaves valuation vulnerable if real 10Y TIPS yields spike.
P/E: 26.4x // EV/EBITDA: 19.3xOptions market prices a ±5.2% implied move with a 0.85 put/call ratio around $94.52 max pain.
IMPL MOVE: ±5.2% // P/C: 0.85Elevated industry capital intensity and customer concentration in Industrial Specialties require continuous execution to defend 8.6% net margins.
NET MARGIN: 8.6% // D/E: 0.55x| FILER | SIDE | $ VALUE |
|---|---|---|
| INSPECT FULL OWNERSHIP LEDGER IN OWN <GO> | ||
| STRIKE / EXP | TYPE | PREMIUM |
|---|---|---|
| INSPECT GEX & CHAIN IN OPT <GO> | ||
Unblur the exact $50,000 delta-adjusted ETF/options hedge ratio for ZBH & activate live FRED threshold breach alerts.